Cabozantinib Plus Nivolumab in Patients with Non–Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial

Kelly N. Fitzgerald, Chung‐Han Lee, Martin H. Voss, Maria I. Carlo, Andrea Knežević, Laura Peralta, Ying‐Bei Chen, Robert A. Lefkowitz, Neil J. Shah, Colette Owens, Deaglan Joseph McHugh, David H. Aggen, Andrew Leonard Laccetti, Ritesh R. Kotecha, Darren R. Feldman, Robert J. Motzer